Menu | |||||||||
---|---|---|---|---|---|---|---|---|---|
Welcome | Committee | Abstracts | Programme | Morphology Quiz | Registration (& Payment) | Hotel Booking | Sponsors | Contact | About Malaysia |
Click for Detailed Programme:
Day 1 (14 April) Day 2 (15 April) Day 3 (16 April)
SCIENTIFIC PROGRAMME DAY 2
Day 2 | ||||||
---|---|---|---|---|---|---|
Time | White cell | Haemostasis & Thrombosis | Red cell | Molecular medicine | Paediatric Haematology | Cell-based therapy |
0815 - 0835 | Lymphoma in Malaysia Bee Ping Chong (Malaysia) | Haemophilia in Malaysia Jameela Sathar (Malaysia) | Red cell enzyme disorders in Malaysia Ainoon Othman (Malaysia) | Molecular research in haematology Gareth Gerrard (United Kingdom) | Paediatric lymphoma: update on management Hamidah Alias (Malaysia) | Cord blood banking in Malaysia Nazahah Mahmud (Malaysia) |
0835 - 0855 | New therapies & strategies in aggressive B cell lymphoma Anas Younes (USA) | Individualizing therapy for haemophilia: selecting the right therapy at the right time Zulaiha Muda (Malaysia) | Red Cell Enzyme & Membrane Disorders : A Global Perspective Mark Layton (United Kingdom) | Gene expression & DNA methylation profiling in MPN Wong Chieh Lee (Malaysia) | Acute leukaemia in Malaysia: a paediatric perspective Hany Ariffin (Malaysia) | Bone marrow stem cell niche & mesenchymal stem cell culture Cheong Soon Keng (Malaysia) |
0855 - 0915 | Treatment of lymphoid malignancies with targeted CAR T-cells Miles Prince (Australia) | Managing the Switch from Plasma to Recombinant Therapy in Clinical Practice Mike Laffan (United Kingdom) | Management of Red Cell Enzyme & Membrane Disorders Mark Layton (United Kingdom) | Targeted sequencing in myeloid disorders Gareth Gerrard (United Kingdom) | Early complications after paediatric SCT: update on management Anselm Lee (Singapore) | Cell therapy for cancer: Current state of the art Dario Campana (Singapore) |
0915 - 0945 | Q & A | Q & A | Q & A | Q & A | Q & A | Q & A |
0945 - 1015 | TEA BREAK | |||||
1015 - 1035 | Multiple myeloma in Malaysia Tan Sen Mui (Malaysia) | How I treat : Thrombosis in unusual sites Lim Soo Min (Malaysia) | Haemolytic anaemia: What is new? Lim Su Hong (Malaysia) | Next generation sequencing for haematological malignancies - evolving tools Kahlil Lawless (Singapore) | Paediatric Thrombosis & Anticoagulation: Issues & Management Zulaiha Muda (Malaysia) | Autologous haemopoietic stem cell-based gene therapy for devastating neural disorder: Early outcomes in metachromatic leucodystrophy patients Lian Qizhou (Hong Kong) |
1035 - 1055 | Management of relapsed/refractory multiple myeloma: an update Daryl Tan (Singapore) | Pulmonary embolism : Who to thrombolyse and who to discharge? Rafeah Tumian (Malaysia) | Rare red cell disorders: An update Mark Layton (United Kingdom) | Genomics of T-cell lymphoma: From sequencing to clinical applications Ong Choon Kiat (Singapore) | Congenital immunodeficiencies: an update Lokman Md Noh (Malaysia) | Mesenchymal stem cells in eye disorders - from regeneration to immune modulation Then Kong Yong (Malaysia) |
1055 - 1115 | Management of multiple myeloma in the molecular era Chng Wee Joo (Singapore) | The latest update on NOACs: from Mx of SPAF to VTE/PE treatment Yap Eng Soo (Singapore) | Role of next generation sequencing in the diagnosis of rare red cell disorders Mark Layton (United Kingdom) | RNA-interference-mediated gene silencing in cancer therapy Teoh Hoon Koon (Malaysia) | Role of immunotherapy in paediatric malignancies Dario Campana (Singapore) | The potential clinical applications based on immuno-modulatory properties of mesenchymal stem cells Shi Yu Fang (China) |
1115 - 1145 | Q & A | Q & A | Q & A | Q & A | Q & A | Q & A |
1145 - 1200 | Poster viewing + Visit booth | |||||
1200 - 1245 | PLENARY 1 | Curing sickle cell disease Thein Swee Lay (USA) | ||||
1245 - 1315 | Lunch symposium - Acquired Haemophilia Paul Giangrande (Novo Nordisk) | Lunch symposium Shaun Fleming (MSD) | Lunch symposium - Current and future treatment of CD30+ Lymphomas Anas Younes (Takeda) | |||
1315 - 1430 | LUNCH BREAK | |||||
1430 - 1530 | Satellite Symposium (3) Yap Eng Soo (Bayer) | MEET-THE-EXPERT: Managing difficult cases of CLL and low grade lymphoma Bryone Kuss (Australia) | MEET-THE-EXPERT: Challenges in the management of iron overload Vip Viprakasit (Thailand) | MEET-THE-EXPERT: Challenges in paediatric & adult HSCT Anselm Lee (Singapore) & Huang Xiao Jun (China) | Royal College of Pathologists of Australasia (RCPA) Workshop Merrole Cole-Sinclair (Australia) | Clinical Research Malaysia Workshop |
1530 - 1545 | TEA BREAK | |||||
1545 - 1700 | Presidential Symposium | |||||
1700 - 1800 | Poster Walk | |||||
1800 - 2200 | Dinner symposium (Roche) |